Shopping Cart 0
Cart Subtotal
AED 0

Laboratorio Reig Jofre SA (RJF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company's product categories include specialized technology products, specialty therapeutic areas, and consumer healthcare. Its specialized technology products include antibiotics, injectable, and freeze-dried products. Reig Jofre offers therapeutic products in the areas of dermatology, gynecology, and respiratory. It develops products in the dosage forms of oral and topical solutions, syrups, ointments, emulsions, micro-emulsions and creams, capsules, tablets, coated tablets and lozenges, among others. The company offers services such as research and development, regulatory services, manufacturing, and licensing of dossiers. The company caters to biotechnology and pharmaceutical companies. Reig Jofre is headquartered in Barcelona, Spain.

Laboratorio Reig Jofre SA (RJF)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11

Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12

Partnerships 13

Laboratorio Reig Jofre and Leanbio Form Joint Venture 13

Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 14

Merger 15

Laboratorio Reig Jofre Merges with Natraceutical 15

Licensing Agreements 16

Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 16

Acquisition 17

Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 17

Laboratorio Reig Jofre SA-Key Competitors 18

Laboratorio Reig Jofre SA-Key Employees 19

Laboratorio Reig Jofre SA-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 21

Recent Developments 22

Financial Announcements 22

Jul 25, 2018: Reig Jofre increases sales by 7%, EBITDA by 12,5% and net profit by 7,5% at the end of june 22

Nov 14, 2017: Reig Jofre Reports Third Quarter 2017 Results 24

Aug 01, 2017: Reig Jofre: Results of First Half 2017 26

May 09, 2017: Reig Jofre: Results for the First Quarter of 2017 28

Corporate Communications 30

Oct 26, 2017: Reig Jofre: Appointments at the head of the corporate and financial management 30

Product News 31

Sep 13, 2017: Reig Jofre Continues to Strengthen its Leadership in ENT with the Launch Of Otospray, 3E Ear Hygiene 31

Mar 23, 2017: Reig Jofre Starts Marketing of a New Injectable Product Cefepime for Hospitals 32

Mar 23, 2017: Reig Jofre Starts Marketing of three New Injectable Products fror Hospitals 33

Other Significant Developments 34

Apr 09, 2018: Reig Jofre Will Invest In Technological Innovation To Triple Its Aseptic Productive Capacity Of Injectable And Lyophilized Products 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Laboratorio Reig Jofre SA, Deals By Therapy Area, 2012 to YTD 2018 8

Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11

Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12

Laboratorio Reig Jofre and Leanbio Form Joint Venture 13

Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 14

Laboratorio Reig Jofre Merges with Natraceutical 15

Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 16

Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 17

Laboratorio Reig Jofre SA, Key Competitors 18

Laboratorio Reig Jofre SA, Key Employees 19

Laboratorio Reig Jofre SA, Other Locations 20

Laboratorio Reig Jofre SA, Subsidiaries 20

Laboratorio Reig Jofre SA, Joint Venture 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Laboratorio Reig Jofre SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company's product categories include specialized technology products, specialty therapeutic areas, and consumer healthcare. Its specialized technology products include antibiotics, injectable, and freeze-dried products. Reig Jofre offers therapeutic products in the areas of dermatology, gynecology, and respiratory. It develops products in the dosage forms of oral and topical solutions, syrups, ointments, emulsions, micro-emulsions and creams, capsules, tablets, coated tablets and lozenges, among others. The company offers services such as research and development, regulatory services, manufacturing, and licensing of dossiers. The company caters to biotechnology and pharmaceutical companies. Reig Jofre is headquartered in Barcelona, Spain.

Laboratorio Reig Jofre SA (RJF)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11

Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12

Partnerships 13

Laboratorio Reig Jofre and Leanbio Form Joint Venture 13

Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 14

Merger 15

Laboratorio Reig Jofre Merges with Natraceutical 15

Licensing Agreements 16

Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 16

Acquisition 17

Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 17

Laboratorio Reig Jofre SA-Key Competitors 18

Laboratorio Reig Jofre SA-Key Employees 19

Laboratorio Reig Jofre SA-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 21

Recent Developments 22

Financial Announcements 22

Jul 25, 2018: Reig Jofre increases sales by 7%, EBITDA by 12,5% and net profit by 7,5% at the end of june 22

Nov 14, 2017: Reig Jofre Reports Third Quarter 2017 Results 24

Aug 01, 2017: Reig Jofre: Results of First Half 2017 26

May 09, 2017: Reig Jofre: Results for the First Quarter of 2017 28

Corporate Communications 30

Oct 26, 2017: Reig Jofre: Appointments at the head of the corporate and financial management 30

Product News 31

Sep 13, 2017: Reig Jofre Continues to Strengthen its Leadership in ENT with the Launch Of Otospray, 3E Ear Hygiene 31

Mar 23, 2017: Reig Jofre Starts Marketing of a New Injectable Product Cefepime for Hospitals 32

Mar 23, 2017: Reig Jofre Starts Marketing of three New Injectable Products fror Hospitals 33

Other Significant Developments 34

Apr 09, 2018: Reig Jofre Will Invest In Technological Innovation To Triple Its Aseptic Productive Capacity Of Injectable And Lyophilized Products 34

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Laboratorio Reig Jofre SA, Deals By Therapy Area, 2012 to YTD 2018 8

Laboratorio Reig Jofre SA, Medical Devices Deals, 2012 to YTD 2018 9

Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11

Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12

Laboratorio Reig Jofre and Leanbio Form Joint Venture 13

Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 14

Laboratorio Reig Jofre Merges with Natraceutical 15

Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 16

Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 17

Laboratorio Reig Jofre SA, Key Competitors 18

Laboratorio Reig Jofre SA, Key Employees 19

Laboratorio Reig Jofre SA, Other Locations 20

Laboratorio Reig Jofre SA, Subsidiaries 20

Laboratorio Reig Jofre SA, Joint Venture 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Laboratorio Reig Jofre SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.